首页> 外文期刊>The pharmaceutical journal >Cancer-related anaemia is undertreated
【24h】

Cancer-related anaemia is undertreated

机译:癌症相关的贫血治疗不足

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer-related anaemia is seriously under-treated,with less than one-third of anaemic patients receiving treatment,according to a study presented at the European Cancer Conference in Paris earlier this month.The European Cancer Anaemia Study included more than 15,000 cancer patients,who were not receiving chemotherapy at the time of enrolment.Results show that 32 per cent were anaemic - 24 per cent had haemoglobin(Hb)levels between 10.0 and 11.9g/dL and 8 per cent had Hb levels lower than 10.0g/dL.However,only 31 per cent of these received any treatment for anaemia.
机译:根据本月早些时候在巴黎举行的欧洲癌症会议上发表的一项研究,与癌症相关的贫血得到了严重的治疗,只有不到三分之一的贫血患者接受了治疗。欧洲癌症贫血研究包括15,000多名癌症患者,结果显示,有32%的人贫血-24%的血红蛋白(Hb)水平在10.0至11.9g / dL之间,而8%的血红蛋白水平低于10.0g / dL。但是,其中只有31%接受过任何贫血治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号